Schaeffer's Top Stock Picks for '25

Stocks Higher as Energy Sector Shines

The Dow is on track for an 11th consecutive win

Managing Editor
Jul 24, 2023 at 11:59 AM
facebook X logo linkedin


Stocks are moving higher today, as the surging energy sector gives the market a boost. The Dow Jones Industrial Average (DJI) is on track for its 11th-straight win, while the S&P 500 Index (SPX) and Nasdaq Composite (IXIC) sit higher as well. Should these gains hold, this will mark the blue-chip index's longest win streak since February 2017. This week all eyes are on the Fed's latest interest rate decision, which is due out Wednesday. 

Continue reading for more on today's market, including: 

  • Options traders are taking a slice of this pizza giant.
  • Shopify stock receives a pair of bull notes.
  • Plus, Pharma stock with hot options; Barbenheimer takes over; and Kodiak stock dragged on drug failure.

mmcchart

Horizon Therapeutics PLC (NASDAQ:HZNP) is seeing unusual options activity today, with 72,000 calls and 24,000 puts traded so far, or 12 times the average intraday amount. Most popular is the 105-strike call in both the August and September series, with new positions being opened at the latter. While the catalyst driving today's options surge is unclear, the pharma giant reported a failed mid-stage 2 trial for Systemic lupus erythematosus (SLE) drug daxdilimab on Friday. HZNP has struggled in 2023, last seen down 13% for the time period.
 
AMC Entertainment Holdings Inc (NYSE:AMC) is dancing at the top of the New York Stock Exchange (NYSE) today, up 23% at $5.41 at last check, after the dubbed "Barbenheimer" weekend posted blowout box office results. Greta Gerwig's Barbie logged record number for a female director, and Christopher Nolan's Oppenheimer also rolled out impressive revenue. An estimated 7.8 million movie goers hit AMC theaters this weekend, sending the stock toward its best day since March 2022.

 

AMCmmcchart

One of the worst stocks on the Nasdaq, meanwhile, is Kodiak Sciences Inc (NASDAQ:KOD). The equity is down 50% at $3.65 at last glance, after the company halted its diabetic macular edema (DME) eye drug tarcocimab tedromer, following two failed trials. KOD is on track for its worst day since February 2022 and is down 50% year-to-date.
 
 

Which of These SUB-$5 Stocks Could 26x From Here? (AD)

He called a rare 11x on Tesla…

Then he called a 26x on Workhorse…

Then an even rarer 35x on Nio Inc…

Now Tim Bohen says these 5 tiny “America First” stocks are next up in 2025.

They’re trading for less than $5 right now.

But thanks to Elon & Trump’s new alliance…

They could be off to the races in Trump’s first 100 days.

And right now for a limited time…

You can get the names & tickers for just $1 here. (AD)

10 Stock Picks FREE
 
 

Featured Articles from Trusted Partners:

🚀 One Stock Pick Could Change Everything in 2025
What if one stock pick could define your success next year? Get 10 expert-vetted stocks set for 2025—plus 5 bonus picks to watch now. Get the Report →

🆕 New Options Need New Trading Strategies
Zero-DTE options are the newest (and hottest) options to trade.  Professional traders have rushed into the market and are making a mint.  Don’t get left behind - learn all about these options, how to trade them, market setups to profit from, plus much more. Download now →

👀 Revealed: 3 Defensive Stocks for Your Portfolio
Worried about the market? This free report reveals 3 under-the-radar defensive stocks for uncertain times in any kind of economy.

 

 
 

FREE Report Download

 

Follow us on X, Follow us on Twitter